Caricamento...
Nicotinamide reduces renal interstitial fibrosis by suppressing tubular injury and inflammation
Renal interstitial fibrosis is a common pathological feature in progressive kidney diseases currently lacking effective treatment. Nicotinamide (NAM), a member of water‐soluble vitamin B family, was recently suggested to have a therapeutic potential for acute kidney injury (AKI) in mice and humans....
Salvato in:
| Pubblicato in: | J Cell Mol Med |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6533567/ https://ncbi.nlm.nih.gov/pubmed/30993884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.14285 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|